Skip to content
IFAI

Broad Institute

Company3 stories

  1. ResearchReach 31

    Microsoft designs AI assistant to diagnose rare genetic diseases

    Microsoft Research, Drexel University, and the Broad Institute just detailed an AI assistant designed to support whole genome sequencing analysis. The tool synthesizes complex biomedical literature on gene variants and automatically flags unsolved patient cases when new evidence emerges. Why it matters: Fewer than 50% of rare disease cases get an initial diagnosis, and AI sensemaking could clear backlogs by keeping cold cases active.

  2. ResearchReach 35

    MIT's generative AI designs brand-new superbug killers

    MIT researchers just used generative AI algorithms to dream up over 36 million theoretical molecules, successfully discovering novel antibiotic candidates that kill drug-resistant gonorrhea and MRSA in mice. Rather than modifying existing drugs, these candidates feature completely unseen chemical structures that attack bacterial cell membranes.

  3. ResearchReach 36

    AI discovers new antibiotic class to kill superbugs

    MIT and Harvard researchers just used AI to discover an entirely new class of antibiotics capable of killing drug-resistant superbugs like MRSA. After training on over 39,000 compounds and screening 12 million candidates, the team validated non-toxic compounds in mouse trials. Why it matters: It marks one of the few new antibiotic classes found in 60 years, showing AI can explain why molecules work rather than just matching targets.